Ginsenoside Re

Ginsenoside Re is an inhibitor of NF-kB and JNK used in studies of MAPK / ERK Signaling and NF-kB Signaling and related signaling programs. In practice, this places the compound in experiments that measure mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and inflammatory transcriptional control and stress-responsive survival signaling in cell signaling, immunology, and inflammation models.

By inhibiting NF-kB and JNK, Ginsenoside Re can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and inflammatory transcriptional control and stress-responsive survival signaling. The signaling pathway modulator annotation adds relevance to pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping in the same experimental setting. In cell signaling, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving NF-kB and JNK
• Pathway perturbation studies connected to MAPK / ERK Signaling and NF-kB Signaling and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Pathway-reporter and mechanistic-phenotyping studies

Overall, Ginsenoside Re is appropriate when a defined chemical perturbant is needed to connect NF-kB and JNK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cell signaling, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.